1 |
Deng L, Liao L, Zhang YL, Hu SY, Yang SY, Ma XY, Huang MY, Zhang FL, Li DQ. MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression. Cancer Lett 2023;:216124. [PMID: 36907504 DOI: 10.1016/j.canlet.2023.216124] [Reference Citation Analysis]
|
2 |
Sun G, Wei Y, Zhou B, Wang M, Luan R, Bai Y, Li H, Wang S, Zheng D, Wang C, Wang S, Zeng K, Liu S, Lin L, He M, Zhang Q, Zhao Y. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer. Cell Death Differ 2023. [PMID: 36828916 DOI: 10.1038/s41418-023-01135-y] [Reference Citation Analysis]
|
3 |
Hernández-Quiles M, Baak R, Orea-Soufi A, Borgman A, den Haan S, Sobrevals Alcaraz P, Jongejan A, van Es R, Velasco G, Vos H, Kalkhoven E. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells. Int J Mol Sci 2022;23:10535. [PMID: 36142452 DOI: 10.3390/ijms231810535] [Reference Citation Analysis]
|